Copiktra savings card: $5 or less a month with commercial insurance

How to pay the least

Ask for the cash price

Copiktra

We didn’t find one.

Ask your pharmacy for Copiktra’s cash price, and one or two other pharmacies too.
Copiktra’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameCopiktra

Authorized genericduvelisib

Regular genericduvelisib

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Copiktra?

The original

–

Brand nameThe maker’s card

COPIKTRA Co-Pay Program (Secura Care)

Savings card from Secura Bio

No insuranceNeeds insuranceNo cash price listed.

Insurance $5 or less a month

The card takes up to $25,000 a year off your co-pay.

Or call 1-844-973-2872.

In the maker’s words

“With the Co-Pay Program, eligible, commercially insured patients pay no more than $5 per month up to an annual maximum of $25,000 per calendar year.”

From the maker’s offer on copiktra.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Copiktra itself, from the same company, sold without the brand name, and usually for less. For now Copiktra is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

COPIKTRA is a kinase inhibitor indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after at least two prior lines lines of systemic therapy.

Limitations of Use: COPIKTRA is not indicated or recommended for the treatment of any patients with CLL or SLL as initial or second line treatment due to an increased risk of treatment-related mortality.

Source: the FDA label for Copiktra (Secura Bio, Inc), December 18, 2025. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/copiktra/